SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 84 filers reported holding SERES THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 2.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $130,000 | -85.4% | 36,369 | -85.9% | 0.02% | -28.0% |
| Q4 2019 | $888,000 | +13.0% | 257,463 | +31.4% | 0.02% | +31.6% |
| Q3 2019 | $786,000 | +991.7% | 195,916 | +1777.1% | 0.02% | +850.0% |
| Q1 2019 | $72,000 | -84.2% | 10,437 | -79.9% | 0.00% | -77.8% |
| Q2 2018 | $455,000 | +0.4% | 51,931 | -15.9% | 0.01% | -10.0% |
| Q1 2018 | $453,000 | +17.1% | 61,776 | +63.9% | 0.01% | +25.0% |
| Q4 2017 | $387,000 | +49.4% | 37,685 | +63.8% | 0.01% | +33.3% |
| Q1 2017 | $259,000 | -37.6% | 23,011 | -45.1% | 0.01% | -60.0% |
| Q4 2016 | $415,000 | -59.2% | 41,922 | +19.8% | 0.02% | -54.5% |
| Q2 2016 | $1,016,000 | -71.9% | 34,988 | -71.3% | 0.03% | -71.1% |
| Q3 2015 | $3,610,000 | -28.6% | 121,800 | 0.0% | 0.11% | -16.8% |
| Q2 2015 | $5,055,000 | – | 121,800 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |